CIRS

The EPA reports that 100% of buildings contain some level of mold spores. Cholestyramine is a bile-sequestering agent used in CIRS that binds biotoxin-laden bile in the gut and eliminates it through stool, breaking the reabsorption cycle. CIRS involves a genetic susceptibility that prevents the body from properly clearing biotoxins. In CIRS-susceptible individuals, biotoxins processed through the liver into bile are reabsorbed in the colon rather than eliminated, creating a continuous toxic loop. CIRS is diagnosed using the Visual Contrast Sensitivity test and melanocyte-stimulating hormone levels. Mold exposure coincided with the onset of amenorrhea, hypothyroidism, and other systemic symptoms. The first step in CIRS treatment is complete environmental avoidance of all mold sources.